Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)

Nigeria flag Nigeria · Delayed Price · Currency is NGN
11.00
+0.35 (3.29%)
At close: Mar 5, 2026
Market Cap47.00B +254.8%
Revenue (ttm)7.37B +64.3%
Net Income982.11M
EPS0.23
Shares Out4.27B
PE Ratio47.87
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,118,683
Average Volume4,794,574
Open11.00
Previous Close10.65
Day's Range11.00 - 11.00
52-Week Range2.42 - 16.15
Beta0.79
RSI47.31
Earnings DateJan 28, 2026

About NGX:NEIMETH

Neimeth International Pharmaceuticals Plc manufactures and markets pharmaceutical and animal health products in Nigeria and Ghana. It provides health care, ethical, and veterinary related products; and poultry and animal range of anthelmintic products, as well as production enhancing medicaments. The company was formerly known as Pfizer Inc. and changed its name to Neimeth International Pharmaceuticals Plc. In 1997. Neimeth International Pharmaceuticals Plc was incorporated in 1957 and is based in Lagos, Nigeria. [Read more]

Industry Pharmaceutical Preparations
Founded 1957
Employees 175
Stock Exchange Nigerian Stock Exchange
Ticker Symbol NEIMETH
Full Company Profile

Financial Performance

Financial Statements